Skip to content
Products & Services · Total revenues

Research Services Obligation — Total revenues

Alnylam Pharmaceuticals Research Services Obligation — Total revenues increased by 3014.1% to $6.63M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 52.0%, from $13.81M to $6.63M. Over 4 years (FY 2021 to FY 2025), Research Services Obligation — Total revenues shows relatively stable performance with a 1.3% CAGR.

Analysis

StatementSegment
First reportedQ1 2019
Last reportedQ1 2026Apr 30, 2026
Rolls up toTotal Revenue
Metric ID: alny_segment_research_services_obligation_total_revenues

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$10.2M$8.9M$8.7M$7.2M$1.6M$10.3M$9.5M$10.7M-$17M$73M$13.5M$14.7M$4M$11.1M$9.3M$13.81M$12.96M$12.54M$213K$6.63M
QoQ Change-12.7%-2.2%-17.2%-77.8%+543.8%-7.8%+12.6%-258.9%+529.4%-81.5%+8.9%-72.8%+177.5%-16.2%+48.5%-6.2%-3.2%-98.3%>999%
YoY Change-84.3%+15.7%+9.2%+48.6%<-999%+608.7%+42.1%+37.4%+123.5%-84.8%-31.1%-6.1%+223.9%+13.0%-97.7%-52.0%
Range-$17M$73M
CAGR-8.7%
Avg YoY Growth-24.8%
Median YoY Growth+11.1%

Frequently Asked Questions

What is Alnylam Pharmaceuticals's research services obligation — total revenues?
Alnylam Pharmaceuticals (ALNY) reported research services obligation — total revenues of $6.63M in Q1 2026.
How has Alnylam Pharmaceuticals's research services obligation — total revenues changed year-over-year?
Alnylam Pharmaceuticals's research services obligation — total revenues decreased by 52.0% year-over-year, from $13.81M to $6.63M.
What is the long-term trend for Alnylam Pharmaceuticals's research services obligation — total revenues?
Over 4 years (2021 to 2025), Alnylam Pharmaceuticals's research services obligation — total revenues has grown at a 1.3% compound annual growth rate (CAGR), from $37.6M to $39.52M.